Opioids

Tris' next-gen pain drug completes trio of clinical wins

Tris Pharma’s opioid alternative has scored a third win, providing the biotech with the data needed to take the pain relief drug to the FDA this year.

James Waldron Mar 6, 2025 8:30am

Novo Holdings-backed SiteOne charges up with $100M financing

Dec 18, 2024 7:00am

AstraZeneca cans ph. 2 OUD drug over antifungal interaction

Nov 22, 2024 4:41am

With 4 remaining staffers, CNS-focused Trevena nears end of road

Nov 7, 2024 10:40am

FDA approves first DNA test for opioid use disorder risks

Dec 21, 2023 10:18am

Click, Indivior to make digital therapeutics for addiction

Sep 8, 2023 1:13pm